Friday, 5 Sep 2008 | Source: The Associated Press
Shares of some top pharmaceuticals companies were mixed at the close of trading:
Friday, 5 Sep 2008 | Source: The Associated Press
Shares of some top pharmaceuticals companies are mixed at noon:
Friday, 5 Sep 2008 | Source: The Associated Press
Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Friday, 5 Sep 2008 | Source: The Associated Press
Goldman Sachs and Co. downgraded ImClone Systems Inc. stock to "neutral" with a price target of $64 per share, near its current trading price.
Wednesday, 3 Sep 2008 | Source: The Associated Press
ImClone Systems Inc. said Wednesday it has asked regulators to approve its drug Erbitux as a primary treatment for head and neck cancers.
Tuesday, 2 Sep 2008 | Source: The Associated Press
Pfizer Inc. and Bristol-Myers Squibb Co. said Tuesday a midstage safety study showed their experimental blood thinner apixaban did increase patients' risk of bleeding, but may also reduce patients' risk of a second heart attack, stroke or death.
Tuesday, 2 Sep 2008 | Source: The Associated Press
Eli Lilly said Tuesday its experimental blood thinner outperformed Plavix at preventing heart attacks in diabetes patients who have increased risk of heart problems.
Wednesday, 27 Aug 2008 | Source: The Associated Press
Shares of Bristol-Myers Squibb Co. dipped Wednesday after the drug developer said its developing blood thinner apixaban failed in a late-stage study.
Wednesday, 27 Aug 2008 | Source: The Associated Press
Among the stock activity stories for Wednesday, Aug. 27, from AP Financial News:
Wednesday, 27 Aug 2008 | Source: The Associated Press
Eli Lilly & Co. and Amylin Pharmaceuticals Inc. could feel more competitive pressure in the diabetes market as their drug Byetta comes under scrutiny after new patient deaths were reported Tuesday.
Tuesday, 26 Aug 2008 | Source: The Associated Press
A new type of blood thinner being developed by two top pharmaceutical companies didn't meet its goal in a late-stage test of its ability to prevent certain dangerous blood clots, but research for other uses will continue, the companies said late Tuesday.
Friday, 22 Aug 2008 | Source: Reuters
King Pharmaceuticals said Friday that rival Alpharma has rejected a $1.4 billion buyout offer but indicated it is prepared to take the bid directly to shareholders in a move to expand its product offerings.
Thursday, 14 Aug 2008 | Source: Reuters
Biotechnology company ImClone Systems, which rebuffed a $60-per-share takeover offer from Bristol-Myers Squibb, said on Thursday it hired JP Morgan Chase as its financial
adviser.
adviser.
Wednesday, 13 Aug 2008 | Source: Reuters
Biotechnology company Genentech rejected an offer by its majority shareholder, Roche Holding, to acquire the shares of Genentech it does not already own.
Stocks ended sharply lower Thursday as the market got a triple whammy: Oil resumed its ascent, major earnings reports sparked a fresh wave of concern about corporate profits and home sales hit a 10-year low. All three major indexes lost at least 2 percent.
Posts |
COMPANY : Bristol-Myers Squibb Co
5 Sep 2008
Earlier this week I blogged about Eli Lilly's "Coming Soon" banner ad I spotted in the online edition of "The New England Journal of Medicine." It's designed to generate buzz about the company's crucial new bloodthinner that could win Food and Drug Administration approval this month... Read More
29 Aug 2008
For the week and month ending Friday, August 29, 2008,... Read More
27 Aug 2008
It's a booyah-free zone... Read More
27 Aug 2008
Within a 12-hour period five biopharma companies revealed negative drug news that is sending their stocks lower -- in the case of Amylin Pharmaceuticals and Cell Genesys, much lower... Read More
VIDEO | COMPANIES : Bristol-Myers Squibb Co
Finding an energy compromise, with Sen. Mary Landrieu, (D) Louisiana and CNBC's Larry Kudlow.
An outlook on the markets and the economy, with John Ryding, RDQ Economics; Brian Wesbury, First Trust Advisors; and CNB...
A big rally in bank stocks trumped another job loss today, with Jim LaCamp, RBC Dain Rauscher; Michael Pento, Delta Glob...
Discussing what's behind the McCain bounce, with Scott Rasmussen, Rasmussen Reports and CNBC's Larry Kudlow.
More Videos
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes